Cancer History ProjectConversation with The Cancer LetterFree In 1998, a CML patient was out of options. Then she chanced into a treatment–Gleevec June 03, 2022Vol.48 No.22By Deborah Doroshow and Alexandria Carolan
Conversation with The Cancer Letter Jon Chernoff pledges to revive his institution’s “Fox Chaseness” after years of setbacks May 20, 2022Vol.48 No.20By Paul Goldberg
Conversation with The Cancer Letter FDA’s Lola Fashoyin-Aje: It’s time to increase racial diversity in trials—here’s a draft guidance for how this can be done May 06, 2022Vol.48 No.18By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Romania’s Csaba Dégi: We need to be proactive about psychosocial support, because Ukrainians are suffering April 22, 2022Vol.48 No.16By Matthew Bin Han Ong
Conversation with The Cancer Letter At ODAC without sponsors, FDA highlights safety signals in PI3K inhibitor trials April 15, 2022Vol.48 No.15By Paul Goldberg
Conversation with The Cancer LetterFree Yuliya Nogovitsyna: Evacuating children with cancer from Ukraine “a risky operation” as drivers, suppliers are targeted April 15, 2022Vol.48 No.15By Alice Tracey
Conversation with The Cancer LetterFree ECO’s Mike Morrissey: Ukraine is a priority of our lifetime in oncology April 15, 2022Vol.48 No.15By Matthew Bin Han Ong
Conversation with The Cancer LetterFree Ned Sharpless steps down as NCI director April 08, 2022Vol.48 No.14By Matthew Bin Han Ong and Paul Goldberg
Conversation with The Cancer LetterFree Ukraine NCI’s Oleksandr Stakhovskyi: Cancer patients are returning to Kyiv April 08, 2022Vol.48 No.14By Alice Tracey
Conversation with The Cancer Letter In an unprecedented move, Huntsman and Fred Hutch add dramatically to their catchment areas in western U.S. April 01, 2022Vol.48 No.13By Paul Goldberg
